Clinical Features of Autoimmune Nodopathy With Anti-Neurofascin-155 Antibodies in South Koreans.
Hyun Ji LyouYeon Hak ChungMin Ju KimMinGi KimMi Young JeonSeung Woo KimHa Young ShinByoung Joon KimPublished in: Journal of clinical neurology (Seoul, Korea) (2024)
The clinical characteristics of the patients were consistent with those in previous studies. Anti-NF155 antibody assay is necessary for diagnosing autoimmune nodopathy and its appropriate treatment, especially in young patients with CIDP who present with sensory ataxia and poor therapeutic responses to corticosteroids and IVIg.
Keyphrases
- end stage renal disease
- multiple sclerosis
- ejection fraction
- chronic kidney disease
- newly diagnosed
- signaling pathway
- prognostic factors
- oxidative stress
- peritoneal dialysis
- lps induced
- drug induced
- early onset
- inflammatory response
- patient reported outcomes
- immune response
- replacement therapy
- smoking cessation
- patient reported
- case control